YOLFTbeta
Arch Biopartners Inc

Arch Biopartners Inc

ARCH · V · Healthcare / Biotechnology

0.93CAD-0.09 (-8.82%)

Price History

Full chart

Market Stats

Previous Close1.02
Open1.00
Day Range0.91 – 1.00
52-Week Range0.39 – 1.45
Volume108.00K
Market Cap56.38M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta1.75
50-Day Avg0.96
200-Day Avg0.8241

About

Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops CKD Platform, therapeutics targeting chronic kidney disease. Arch Biopartners Inc. is based in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Richard Gabriel Muruve
  • Employees0
  • Headquarters545 King Street West, Toronto, ON, Canada, M5V 1M1, Canada
  • Websitehttps://www.archbiopartners.com

Leadership

  • Mr. Richard Gabriel MuruveCo-Founder, CEO, President & Director · b. 1971
  • Dr. Daniel Abraham Muruve M.D.Co-Founder, Chief Science Officer & Member of Scientific Advisory Board
  • Mr. Andrew Bishop CFACFO & Director · b. 1966
  • Dr. Justin MacDonald Ph.D.Co-Founder & Principal Scientist
  • Dr. Paul BeckCo-Founder & Principal Scientist
  • Mr. Aaron BensonDirector of Communications & Clinical Data Management

Financials

Income Statement

Currency: CAD1997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue9.12K100.00K49.79K349.45K1.71K1.52K2.86M2.68M1.91M1.59M1.64M3.66M----37.69K51.13K37.64K00093.88K67.89K3.89M964.68K1.98M00
Growth (%)-+996.85%-50.21%+601.82%-99.51%-10.97%+188281.62%-6.38%-28.77%-16.41%+3.01%+122.63%-----+35.65%-26.37%-100.00%----27.69%+5625.22%-75.18%+105.63%-100.00%-
Cost of Revenue-45.80K-46.98K-31.16K-121.62K--1.93M1.55M1.41M954.45K1.08M2.92M----83.04K227.15K383.18K411.85K610.73K1.50M1.50M2.19M4.04M1.47M2.11M--
Gross Profit54.92K146.98K80.95K471.06K1.71K1.52K932.57K1.13M499.22K639.68K563.87K740.30K-----45.35K-176.02K-345.54K-411.85K-610.73K-1.50M-1.40M-2.12M-149.79K-502.88K-128.99K--
Gross Margin602.38%146.98%162.58%134.80%100.00%100.00%32.61%42.17%26.18%40.13%34.34%20.25%-----120.34%-344.30%-917.99%----1494.75%-3126.64%-3.85%-52.13%-6.50%--
Operating Expense1.23M660.51K819.61K1.47M197.20K223.89K1.48M2.19M850.97K574.53K797.18K1.08M----145.87K197.00K561.35K588.80K1.29M1.73M958.82K2.51M1.02M577.15K5.11M--
Operating Income-1.18M-513.54K-738.66K-1.00M-195.50K-222.37K-547.37K-1.06M-351.75K65.15K-233.32K-335.22K-181.79K-141.03K-442.69K-329.38K-191.23K-373.03K-906.89K-1.00M-1.90M-3.23M-2.36M-4.63M-1.16M-1.08M-5.24M-3.56M-1.24M
Operating Margin-12927.30%-513.54%-1483.49%-287.01%-11466.10%-14649.08%-19.14%-39.74%-18.45%4.09%-14.21%-9.17%-----507.38%-729.64%-2409.32%----2516.12%-6826.27%-29.97%-111.96%-264.36%--
EBITDA-1.13M-466.56K-707.50K-881.34K797.52K-211.74K-397.87K-1.02M-304.39K109.30K-188.19K-456.30K-4.66M-7.21M-411.98K-314.51K-172.26K-320.99K-888.83K-980.57K-1.88M-3.17M-2.25M-4.46M-891.54K-1.08M-5.24M-3.53M-1.29M
EBITDA Margin-12424.92%-466.56%-1420.92%-252.21%46775.43%-13948.42%-13.91%-38.08%-15.96%6.86%-11.46%-12.48%-----457.07%-627.86%-2361.33%----2398.64%-6567.07%-22.94%-111.96%-264.36%--
Net Income-2.65M-763.54K-838.66K-1.06M-2.40M-304.38K-519.30K-1.28M-368.98K-18.22K-361.48K-657.52K-4.66M-7.21M-446.27K-329.32K-189.95K-398.51K-839.00K-1.01M-1.90M-3.20M-2.36M-4.63M-1.17M-1.39M-3.33M-3.92M-1.55M
Net Income Margin-29099.87%-763.54%-1684.33%-304.51%-140683.46%-20051.38%-18.16%-47.70%-19.35%-1.14%-22.01%-17.98%-----503.99%-779.48%-2228.96%----2511.41%-6818.28%-30.10%-144.02%-167.71%--
R&D--------------31.35K67.46K21.79K70.15K171.25K162.18K459.40K1.43M1.57M1.96M3.78M1.27M2.20M3.65M9.52K
R&D as % of Total Revenue----------------57.80%137.22%454.94%---1677.69%2885.00%97.20%131.87%111.14%--
Interest Expense-----4.12K69.16K75.27K75.06K77.45K125.58K126.35K-5.09K14.36K14.87K16.85K17.04K18.07K20.07K20.94K64.05K110.29K175.96K273.31K309.33K358.94K389.39K258.13K
Interest Expense % of Total Revenue-----271.48%2.42%2.81%3.94%4.86%7.65%3.46%----44.70%33.32%48.00%---117.48%259.20%7.03%32.07%18.09%--

Balance Sheet

Currency: CAD1997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets357.96K187.16K1.26M2.37M70.56K59.18K1.64M1.38M1.16M953.38K960.41K797.32K1.60K535.28K222.04K93.81K36.83K405.79K649.50K227.03K67.94K672.69K567.98K741.30K2.67M621.64K1.17M935.62K104.53K
Total Liabilities380.18K315.90K205.23K320.21K229.99K42.08K1.57M2.02M2.04M1.60M1.97M2.57M347.56K370.41K397.02K449.23K462.19K412.38K508.02K483.94K631.35K1.72M3.47M4.61M6.55M5.09M6.68M5.28M3.99M
Total Equity-22.22K-128.74K1.06M2.05M-159.43K17.10K73.10K-639.29K-887.26K-644.38K-1.01M-1.77M-345.96K164.87K-174.98K-355.42K-425.37K-6.58K141.48K-256.91K-563.41K-1.05M-2.90M-3.87M-3.88M-4.47M-5.51M-4.35M-3.88M
Cash4.60K42431770.43K1.52K14-41.57K24.25K311.86K1.66K1.87K1.59K506.25K205.57K71.75K25.59K365.11K620.82K199.85K42.58K544.32K400.37K653.68K448.24K506.35K831.27K2.97K2.10K
Total Debt----118.37K-566.41K1.15M1.06M940.39K1.35M1.64M----396.15K353.47K328.28K330.22K349.45K1.48M2.89M3.39M5.16M4.41M5.02M--
Net Debt-4.60K-424-317-70.43K116.85K-14607.98K1.13M1.06M928.52K1.35M1.64M-1.59K-506.25K-205.57K-71.75K370.55K-11.64K-292.55K130.37K306.87K938.93K2.48M2.74M4.72M3.91M4.18M2.77M2.49M

Cash Flow

Currency: CAD1997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-997.15K-503.20K-834.06K-803.47K-251.46K-373.42K-280.87K-961.78K-470.38K119.92K-151.81K-251.16K-400.53K-205.71K-300.68K-293.82K-176.15K-398.51K-474.82K-730.53K-760.17K-3.20M-1.80M-1.90M-2.98M-1.08M-234.07K--
Financing Cash Flow928.29K523.40K1.95M2.05M194.07K372.63K608.26K1.12M207.23K-42.46K194.22K350.71K301.29K681.19K-160.00K130.00K702.20K732.58K309.55K602.90K2.65M1.66M2.16M2.78M-421.37K559.00K1.50M1.58M
Capital Expenditure024.38K513.24K011.52K71626372.11K71.21K7.64K111.98K01.49K0000000000000000
Free Cash Flow-997.15K-527.58K-1.35M-803.47K-262.98K-374.14K-281.13K-1.03M-541.59K112.28K-263.80K-251.16K-402.02K-205.71K-300.68K-293.82K-176.15K-398.51K-474.82K-730.53K-760.17K-3.20M-1.80M-1.90M-2.98M-1.08M-234.07K-2.33M-1.58M
FCF to OCF100.00%104.84%161.54%100.00%104.58%100.19%100.09%107.50%115.14%93.63%173.76%100.00%100.37%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%--

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Jan 22, 2022May 30, 2022Aug 30, 2022Feb 28, 2023May 29, 2023Aug 28, 2023Feb 28, 2024May 30, 2024Aug 30, 2024Jan 28, 2027
EPS Estimate-------------------------------0.01-0.02-0.02-0.02-0.02-0.02-
EPS Actual-0.00-0.00-0.00-0.00-0.01-0.00-0.01-0.00-0.00-0.02-0.00-0.01-0.01-0.03-0.01-0.01-0.01-0.00-0.02-0.01-0.00-0.04-0.03-0.03-0.020.010.01-0.00-0.01-0.00-0.04-0.01-0.01-0.01-0.02-0.01-
Surprise-------------------------------300.00%50.00%50.00%50.00%0.00%50.00%-
Timing---------------------------After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap56.38M
Enterprise Value57.61M
Trailing P/E0.00
Forward P/E0.00
Price / Sales446.93
Price / Book6211.54
EPS-0.05
Book Value-0.059
Revenue (TTM)0
Gross Profit (TTM)-743.83K
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-954.27%
Shares Outstanding67.93M
Shares Float53.61M
Beta1.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%